317 related articles for article (PubMed ID: 33093777)
1. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Amlani B; Elsayed G; Barvalia U; Kanne JP; Meyer KC; Sandbo N; Li Z; McCoy SS
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):136-147. PubMed ID: 33093777
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib in the treatment of primary Sjögren's syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial.
Gao R; Pu J; Wang Y; Wu Z; Liang Y; Song J; Pan S; Han F; Yang L; Xu X; Tang J; Wang X
BMC Pulm Med; 2023 Nov; 23(1):473. PubMed ID: 38007449
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy in primary Sjögren's syndrome with interstitial lung disease: a retrospective cohort study.
Chen MH; Chen CK; Chou HP; Chen MH; Tsai CY; Chang DM
Clin Exp Rheumatol; 2016; 34(6):1077-1084. PubMed ID: 27607895
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G;
Arthritis Res Ther; 2018 Jan; 20(1):17. PubMed ID: 29382380
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease in primary Sjögren's syndrome.
Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Oldham JM; Lee C; Valenzi E; Witt LJ; Adegunsoye A; Hsu S; Chen L; Montner S; Chung JH; Noth I; Vij R; Strek ME
Respir Med; 2016 Dec; 121():117-122. PubMed ID: 27888985
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
Owen C; Ngian GS; Elford K; Moore O; Stevens W; Nikpour M; Rabusa C; Proudman S; Roddy J; Zochling J; Hill C; Sturgess A; Tymms K; Youssef P; Sahhar J
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):170-176. PubMed ID: 27049330
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.
He SH; He YJ; Guo KJ; Liang X; Li SS; Li TF
Clin Rheumatol; 2022 Apr; 41(4):1153-1161. PubMed ID: 34757493
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.
Enomoto Y; Takemura T; Hagiwara E; Iwasawa T; Fukuda Y; Yanagawa N; Sakai F; Baba T; Nagaoka S; Ogura T
PLoS One; 2013; 8(9):e73774. PubMed ID: 24040065
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
[TBL] [Abstract][Full Text] [Related]
15. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
16. The respiratory manifestations in patients with primary Sjögren's syndrome: is interstitial lung disease related to disease activity?
Işık ÖÖ; Yazıcı A; Çefle A
Turk J Med Sci; 2022 Apr; 52(5):1737-1743. PubMed ID: 36422505
[TBL] [Abstract][Full Text] [Related]
17. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
[No Abstract] [Full Text] [Related]
19. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and risk factors for primary Sjögren's syndrome combined with interstitial lung disease: a retrospective study.
Yang Z; Zhao H; Shan L; Wang D
Acta Biochim Pol; 2024; 71():12461. PubMed ID: 38721305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
